Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Bender

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymeraseJulie A Lemm, Mengping Liu, Robert G Gentles, et al.
The Journal of Organic Chemistry|September 7, 2017
Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097Arvind Mathur, Bei Wang, Daniel Smith, et al.
Journal of Medicinal Chemistry|September 23, 2009
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjectsTao Wang, Zhiwei Yin, Zhongxing Zhang, et al.
Journal of Medicinal Chemistry|January 31, 2023
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one ScaffoldEric P Gillis, Kyle Parcella, Michael Bowsher, et al.
Journal of Medicinal Chemistry|April 22, 2017
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical StudiesKap-Sun Yeung, Brett R Beno, Kyle Parcella, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymeraseJulie A Lemm, Mengping Liu, Robert G Gentles, et al.
The Journal of Organic Chemistry|September 7, 2017
Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097Arvind Mathur, Bei Wang, Daniel Smith, et al.
Journal of Medicinal Chemistry|September 23, 2009
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjectsTao Wang, Zhiwei Yin, Zhongxing Zhang, et al.
Journal of Medicinal Chemistry|January 31, 2023
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one ScaffoldEric P Gillis, Kyle Parcella, Michael Bowsher, et al.
Journal of Medicinal Chemistry|April 22, 2017
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical StudiesKap-Sun Yeung, Brett R Beno, Kyle Parcella, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 3